Mark Ware

Dr. Mark A. Ware, MBBS MRCP(UK) MSc is Associate Professor in Family Medicine and Anesthesia at McGill University. He is the Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre, co-Director of the Quebec Pain Research Network, Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids (CCIC) and chair of the International Association for Cannabinoids Medicines (IACM).

He practices pain medicine at the Montreal General Hospital and at the primary care pain clinic of the West Island of Montreal. Dr Ware’s primary research interests are in evaluating the safety and effectiveness of medicines derived from cannabis (cannabinoids), population-based studies of the impact of pain on the population, and the role of complementary therapies in pain and symptom management. His research is funded by the FRSQ, CIHR, and the Louise and Alan Edwards Foundation.

A graduate of the University of the West Indies (MBBS 1992), Dr. Ware worked at the MRC Sickle Cell Unit in Kingston Jamaica from 1996-1998 where he developed his interests in pain management and cannabis therapeutics. He moved to McGill University in Montreal, Canada in 1999 and since then has secured the only two Canadian federal grants to study medical cannabis. He has published over 70 papers on pain and cannabis, 6 book chapters, and given over 150 scientific talks to local, national and international audiences. He has served as an advisor to the Canadian government since 2001 on medical cannabis policy.